Astrazeneca (AZN) Non Operating Investment Income (2018)

Astrazeneca (AZN) posted Non Operating Investment Income of $3.0 million for Q3 2018, down 92.11% on a QoQ basis from $38.0 million in Q2 2018.

Analysis

Astrazeneca (AZN) Non Operating Investment Income (2018) Analysis & Trends

Astrazeneca has reported Non Operating Investment Income for 1 years, with the latest figure at $3.0 million in Q3 2018.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Asml Holding	613.98 Bn	598.00 Bn	5.90 Bn	-
2	Hsbc Holdings	362.87 Bn	362.87 Bn	-	-
3	General Electric	329.85 Bn	320.50 Bn	6.95 Bn	-
4	Astrazeneca	253.49 Bn	248.21 Bn	12.86 Bn	-
5	Citigroup	232.96 Bn	-2,069.35 Bn	24.75 Bn	169.00 Mn
6	Bhp	215.54 Bn	196.99 Bn	-	-
7	Rio Tinto	203.71 Bn	199.33 Bn	-	-
8	Diageo	196.60 Bn	194.57 Bn	-	-
9	Unilever	139.09 Bn	132.06 Bn	-	-
10	Hdfc Bank	117.66 Bn	80.51 Bn	-	-

Historic Data

Download Data